// App-Quantinova.ai

e20637 : Effect of CCR2 antagonism on the metastatic capacity of non-small cell lung cancer cells.

Researchers

Presenter

  • Jun An

Principal Investigators

  • Meijun Long

  • Yong Huang

  • Yun Li

  • Hang Su

  • Junhang Zhang

Medical Centers

  • Department of Thyroid and Breast Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Department of Thyroid and Breast Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • C-C Motif Chemokine Receptor 2

  • Cellular apoptosis susceptibility protein

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final